Upgrade to SI Premium - Free Trial

Adient (ADNT) PT Lowered to $14 at CFRA

January 28, 2025 11:16 AM
CFRA analyst Garrett Nelson lowered the price target on Adient (NYSE: ADNT) to $14.00 (from $16.00) while maintaining a Sell ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles